Clinical Trial Update: Escitalopram and Depression in Elderly Alzheimer's Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating escitalopram for depressive symptoms in elderly Alzheimer's patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: University of British Columbia | Conditions: Depressive Disorder | Phase 3 | Status: TERMINATED